(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 0%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.
Mdxhealth Sa's revenue in 2023 is N/A.On average, 2 Wall Street analysts forecast MDXH's revenue for 2023 to be $1,889,692,390, with the lowest MDXH revenue forecast at $1,886,718,199, and the highest MDXH revenue forecast at $1,892,666,580. On average, 2 Wall Street analysts forecast MDXH's revenue for 2024 to be $2,141,119,626, with the lowest MDXH revenue forecast at $2,135,684,969, and the highest MDXH revenue forecast at $2,146,554,283.
In 2025, MDXH is forecast to generate $2,373,674,272 in revenue, with the lowest revenue forecast at $2,373,674,272 and the highest revenue forecast at $2,373,674,272.